Oppenheimer Reiterates Outperform on enGene Holdings, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Leland Gershell has reiterated an Outperform rating on enGene Holdings (NASDAQ:ENGN) and maintained a $30 price target.
September 24, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer's analyst Leland Gershell has reiterated an Outperform rating for enGene Holdings, maintaining a $30 price target. This suggests confidence in the company's future performance.
The reiteration of an Outperform rating and maintenance of a $30 price target by a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in ENGN's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100